Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus tamoxifen in men with idiopathic infertility
IRCT20260215068878N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in unexplained male infertility (UMI) comparing Letrozole with Tamoxifen (2 arms). Primary endpoints: Sperm parameters, Hormonal profile and 1 more. Started Mar 2026; status: completed.
02
Drugs
letrozoletamoxifen
03
Conditions
unexplained male infertility (UMI)
Beyond the preview
Go deeper on IRCT20260215068878N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260215068878N1.